Cathrine Tipsmark and Kelsi Smith will be attending EHA 2026 in Stockholm from 11–14 June (Thursday to Sunday).
They will be meeting with leaders across Medical Affairs, Market Access, HEOR, Clinical Development, and Commercial teams to discuss:
📊 Real-world evidence (RWE)
📊 External […]
Last week, colleagues from across Quantify Research gathered for our annual summer party at Södra teatern in Stockholm.
The evening was a chance to celebrate the first half of the year, reflect on what we’ve achieved together, and enjoy time […]
Last week, our colleague Alexandra Wennberg represented Quantify Research at EASL 2026, joining leading researchers, clinicians, and industry experts to discuss the latest advances in liver disease research and patient care.
Several themes […]
Our team in Finland has grown significantly this year, and for that, we owe a huge thank you to our excellent clients and the outstanding work delivered by our consultants.
Our Finnish Modelling, Access & Strategy team combines extensive experience from […]
Alexandra Wennberg is on her way to Barcelona for the EASL 2026 Congress ✈️
Over the coming days, she will meet clients and colleagues to discuss real-world evidence in liver disease and share perspectives from the Quantify Research Liver Disease Platform.
Nordic […]
A strong research career often starts with curiosity and consistency.
We are happy to share that Sanjana has transitioned from intern to Research Analyst within Quantify Research’s Evidence Review and Synthesis team in India.
Since joining as an intern in October 2025, she […]
Quantify Research will be attending ISPOR 2026 in Philadelphia (17–20 May) as part of the athagoras Group.
Joining from Quantify:
• Puneet Kaushik
• Kelsi Smith
• Abraham Choong
TLV’s recent decision on Fabhalta provides further evidence of how Sweden applies higher acceptable ICERs in very rare conditions.
Fabhalta was assessed for a very rare, severe chronic kidney disease population. Following three-party negotiations, TLV’s base case, including the confidential agreement, […]
The Swedish HTA agency TLV has announced changes to the timeline and content of its upcoming guidance on reimbursement and pricing of medicines.
Key points from the update:
📍The previously communicated timeline has been postponed. The revised guidance will enter into force […]